Lymphedema Study for Arm or Leg Lymphedema
Trial ID or NCT#
NCT02257970
Status
NOT RECRUITING
Purpose
This study compares the effectiveness of a study drug versus placebo in the treatment of lymphedema.
Official Title
Placebo-controlled, Case-controlled, Open Label Therapeutic Trial for Unilateral or Bilateral Lymphedema of Arm or Leg.
Eligibility Criteria
Ages Eligible for Study: 18 Years to 90 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
- * a history of lymphedema of one or more limbs (unilateral or bilateral), with a duration of \> 6 months.
Exclusion Criteria:
- * Patients with active cancer, infection or bleeding tendency will be excluded.* We will also exclude patients with medical contraindications to NSAIDs, including history of allergies, know gastrointestinal intolerance, or other serious systemic illness (e.g., renal failure, hepatic dysfunction, congestive heart failure, neurological or psychological impairment) that would impair the patients' ability to participate.* Minors (\<18 years of age) \*\>90 years of age
Investigator(s)
Stanley G. Rockson, MD
Cardiologist
Allan and Tina Neill Professor of Lymphatic Research and Medicine
Contact us to find out if this trial is right for you.
Contact
Leslie Roche, RN
650-723-1396
View on ClinicalTrials.gov
